Regulated Online Casinos using Military-Grade Technology to Outsmart Cyber Criminals 10-09-2024, 14:35

Watsco to Present at the J.P. Morgan 2023 Industrials 14-03-2023, 23:14

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00